Tanner M Johnson

7PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Epidemiological modellingPharmaceutical delivery technologiesBehavioural epidemiologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 22, 2026
Beyond 'One Size Fits All': Abatement of Linezolid-Induced Thrombocytopenia Through Therapeutic Drug Monitoring and Precision Dosing-A Case Study.

|Oct 21, 2025
Posaconazole enteral tube administration in adults: pharmacokinetic target attainment of oral suspension compared with crushed delayed-release tablet.

Nirjan Bhattarai, Ryan W Stevens, Patrick M Wieruszewski

|Aug 21, 2023
Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy.

Tanner M Johnson, Leah C Whitman Webster, Meera Mehta

|Oct 19, 2021
Real-World Comparison of Bezlotoxumab to Standard of Care Therapy for Prevention of Recurrent Clostridioides difficile Infection in Patients at High Risk for Recurrence.

Tanner M Johnson, Kyle C Molina, Amanda H Howard

|Jul 15, 2021
Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients.

Tanner M Johnson, Amanda H Howard, Matthew A Miller

|Sep 04, 2020
Predictors of vaccination rates in people living with HIV followed at a specialty care clinic.

Tanner M Johnson, Donald G Klepser, Sara H Bares

Pageof 2

Frequent Collaborators

2 joint publications

Ryan W Stevens

1 joint publications

Sara H Bares

1 joint publications

Christina G Rivera

1 joint publications

Nirjan Bhattarai